Authors: LOFTS FJ EVANS TRJ WASTNAGE R MANSI JL

Citation: Fj. Lofts et al., MAGNESIUM SUPPLEMENTS WITH CISPLATIN CHEMOTHERAPY, European journal of cancer, 32A(3), 1996, pp. 556-557

Authors: EVANS TRJ HARPER CL BEVERIDGE IG WASTNAGE R MANSI JL

Citation: Trj. Evans et al., A RANDOMIZED STUDY TO DETERMINE WHETHER ROUTINE INTRAVENOUS MAGNESIUMSUPPLEMENTS ARE NECESSARY IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY WITH CONTINUOUS-INFUSION 5-FLUOROURACIL, European journal of cancer, 31A(2), 1995, pp. 174-178

Authors: MANSI JL EVANS TRJ SMITH A OAKLEY C WASTNAGE R DALGLEISH A

Citation: Jl. Mansi et al., SHOULD WE BE USING 5-HT3 ANTAGONISTS AS 1ST LINE ANTIEMETIC THERAPY IN CISPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 4(5), 1993, pp. 433-434